Endpoint · computePOSTapi.magentlab.com /api/calc/hfa_icos_bcr_abl
Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL.
Read more
Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL. Class is very_high, high, medium, or low from published very-high and high factors plus Medium 1/2 points (0–1 low, 2–4 medium, ≥5 high). Caller assigns the 10-year CVD >20% threshold; magent does not compute that score. Not a medical device or treatment order.Overview
Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.005 per call
Paid calls
none yet
delivery unknown until someone pays
More info
Seller?
URL
https://api.magentlab.com/api/calc/hfa_icos_bcr_abl
Seen
first 2 months ago · last 32 days ago
44 free handshakes
Payment
Pays through
x402
Offered on?
Base USDC
Listed on?
Base
Handshakescomputed 17 days ago
0.407 from 21 free handshakes over 30 days · UNRATED ?
| Component | Weight | Measured | Lower bound ? | Adds | Short ? | Uncertain ? | |
|---|---|---|---|---|---|---|---|
| livenesscosts the most it answered at all |
0.60 | 0.57 | 0.346 | 0.207 | −0.260 | −0.132 | |
| latency p95 it answered as fast as its class |
0.20 | 0.00 | 0.000 | 0.000 | −0.200 | 0 | |
| price stability the price stayed where it was listed |
0.20 | 1.00 | 1.000 | 0.200 | 0 | 0 | |
| Composite | 1.00 | 0.407 | gap to 1.000 = 0.593 · 0.460 short · 0.132 uncertain | 0.407 | −0.460 | −0.132 |
Not measured: correctness · nobody paid; honesty · nobody paid; schema conformance · no answer had a published shape to check
BURN_INFREE_TIER_ONLY
Verify it yourself
npx teppi-check https://api.magentlab.com/api/calc/hfa_icos_bcr_ablcurl -s https://api.teppi.xyz/v1/trust/cap_01M1RD9JSAQTR9PSYA55C60V7K